Clinic
Southfield City Urgent Care PC
Southfield City Urgent Care PC was paid $8.56M by Medicaid between Jan 2018 and Dec 2024, across 76 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoSOUTHFIELD CITY URGENT CARE PC
SOUTHFIELD, MI 48075
SOUTHFIELD, MI 48075
33aNPI1811278716assigned 09/06/2011
33bProvider typeUrgent Care Clinic/Center
28Total paid$8.56M
24GClaims306,625
24DCodes billed76
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Michigan
Rank by total paid#5 of 239
Median peer was paid$346K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,142 | $482K | |
| 2019 | 17,379 | $534K | |
| 2020 | 20,684 | $616K | |
| 2021 | 45,147 | $1.45M | |
| 2022 | 60,510 | $1.63M | |
| 2023 | 89,728 | $2.31M | |
| 2024incomplete | 57,035 | $1.54M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 52,390 | 47,911 | $2.78M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 23% | 30,947 | 30,801 | $2.00M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 20,332 | 19,307 | $1.37M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.3% | 28,015 | 25,965 | $714K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.1% | 5,757 | 5,730 | $524K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 18,422 | 9,328 | $211K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 11,838 | 11,563 | $127K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.5% | 2,479 | 2,475 | $125K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 3,093 | 2,949 | $119K |
| 81025 | 1.1% | 17,178 | 16,420 | $92K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 12,256 | 11,720 | $92K |
| 99058 | <1% | 804 | 699 | $48K |
64 more codes
| 81002 | <1% | 23,041 | $48K | |
| 99000 | <1% | 29,842 | $40K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,687 | $31K |
| 73130 | <1% | 1,207 | $21K | |
| 16020 | <1% | 456 | $18K | |
| 73630 | <1% | 1,099 | $18K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 190 | $18K |
| 10060 | <1% | 217 | $14K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 334 | $13K |
| 69210 | <1% | 572 | $12K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,156 | $12K |
| 73610 | <1% | 638 | $11K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 2,157 | $10K |
| 73562 | <1% | 450 | $9K | |
| 99205 | Prolong outpt/office vis | <1% | 73 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,496 | $8K |
| 12001 | <1% | 150 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,054 | $7K |
| 99001 | <1% | 2,946 | $5K | |
| 87807 | <1% | 791 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 405 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 135 | $5K |
| 93000 | <1% | 639 | $4K | |
| 73030 | <1% | 196 | $4K | |
| 73110 | <1% | 137 | $3K | |
| 29540 | <1% | 191 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,949 | $2K |
| 90714 | <1% | 90 | $2K | |
| 87634 | <1% | 85 | $2K | |
| 82962 | <1% | 762 | $2K | |
| 99459 | <1% | 138 | $1K | |
| 72100 | <1% | 56 | $1K | |
| 29530 | <1% | 77 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 76 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 76 | $1K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 72 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 865 | $871.03 |
| 74018 | <1% | 46 | $750.07 | |
| 90715 | <1% | 50 | $660.29 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 221 | $543.41 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 1,232 | $422.26 |
| 71047 | <1% | 31 | $405.75 | |
| 73090 | <1% | 14 | $225.99 | |
| 29260 | <1% | 13 | $220.31 | |
| 86328 | <1% | 15 | $189.88 | |
| 29280 | <1% | 14 | $180.12 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 474 | $90.34 |
| A6451 | Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard | <1% | 467 | $62.70 |
| Q4049 | Finger splint, static | <1% | 48 | $62.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 77 | $58.53 |
| S9083 | Global fee urgent care centers | <1% | 87 | $50.00 |
| 86308 | <1% | 14 | $30.17 | |
| 99051 | <1% | 444 | $7.07 | |
| 36410 | <1% | 591 | $6.42 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $5.88 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 14,392 | $1.32 |
| G9498 | Antibiotic regimen prescribed | 0% | 15 | $0.00 |
| 99072 | 0% | 441 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 0% | 621 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 26 | $0.00 |
| 99050 | 0% | 174 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 27 | $0.00 |
| S0630 | Removal of sutures; by a physician other than the physician who originally closed the wound | 0% | 33 | $0.00 |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAMOUD, LENA (ADMINSTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Roseville Urgent Care, PC | Roseville, MI | $6.52M |
| Get Well Urgent Care Sterling Heights PLC | Sterling Heights, MI | $2.69M |
| Get Well Urgent Care Dearborn PLC | Dearborn, MI | $1.19M |
| Get Well Urgent Care Dearborn Heights PLC | Dearborn Heights, MI | $774K |
| Get Well Urgent Care Shelby PLC | Shelby Township, MI | $483K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.